Articles with "aromatase inhibitor" as a keyword



Photo from wikipedia

Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

Sign Up to like & get
recommendations!
Published in 2019 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2019.11080

Abstract: Key Points Question Is fat body mass associated with the prevalence of vertebral fracture in patients with breast cancer undergoing aromatase inhibitor therapy? Findings This cross-sectional study of 556 postmenopausal women with early-stage breast cancer… read more here.

Keywords: body mass; fat body; aromatase inhibitor; breast cancer ... See more keywords
Photo from wikipedia

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.41720

Abstract: This randomized clinical trial of women with breast cancer assesses whether short-term acupuncture reduces long-term aromatase inhibitor–related joint pain compared with sham acupuncture or a waiting list control. read more here.

Keywords: joint pain; acupuncture; related joint; sham acupuncture ... See more keywords
Photo by nci from unsplash

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Sign Up to like & get
recommendations!
Published in 2019 at "Clinical Pharmacology and Therapeutics"

DOI: 10.1002/cpt.1359

Abstract: Anastrozole is a widely prescribed aromatase inhibitor for the therapy of estrogen receptor positive (ER+) breast cancer. We performed a genome‐wide association study (GWAS) for plasma anastrozole concentrations in 687 postmenopausal women with ER+ breast… read more here.

Keywords: genome wide; slc38a7; aromatase inhibitor; epistatic interaction ... See more keywords
Photo by oliverragfelt from unsplash

Pulmonary embolism in adolescent with COVID‐19 during aromatase inhibitor therapy

Sign Up to like & get
recommendations!
Published in 2022 at "Pediatric Pulmonology"

DOI: 10.1002/ppul.25944

Abstract: Our case underlines the fact that pediatric patients with COVID-19 could be in risk of developing severe VTE, including PE, especially in the presence of underlying risk factors that enhance the thrombotic mechanisms of SARS-CoV-2.… read more here.

Keywords: aromatase inhibitor; embolism adolescent; pulmonary embolism; adolescent covid ... See more keywords
Photo from wikipedia

Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Cancer Research and Clinical Oncology"

DOI: 10.1007/s00432-017-2539-7

Abstract: BackgroundOur goal was to compare the survival advantage of tamoxifen (TAM) and aromatase inhibitor (AI) in female (FBC) and male breast cancer (MBC).Patients and methodsWe performed a retrospective study of 2785 FBC and 257 MBC… read more here.

Keywords: aromatase inhibitor; tam treated; breast cancer; mbc patients ... See more keywords
Photo from wikipedia

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events

Sign Up to like & get
recommendations!
Published in 2020 at "Dermatology and Therapy"

DOI: 10.1007/s13555-020-00353-3

Abstract: Anastrozole is an aromatase inhibitor. Anastrozole competitively inhibits the aromatase enzyme, which synthesizes estrogen. It is used for estrogen receptor-positive breast cancers. A woman with breast cancer and anastrozole-induced dermatitis is described; the cutaneous side… read more here.

Keywords: aromatase inhibitor; induced dermatitis; anastrozole induced; aromatase ... See more keywords
Photo by finnnyc from unsplash

Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical Breast Cancer"

DOI: 10.1016/j.clbc.2017.03.002

Abstract: Background Toxicity can lead to noncontinuation of adjuvant endocrine therapy. We hypothesized that endocrine therapy‐induced changes in grip strength would predict for early discontinuation of therapy because of musculoskeletal toxicity and would be associated with… read more here.

Keywords: endocrine therapy; aromatase inhibitor; grip strength; discontinuation ... See more keywords
Photo from wikipedia

Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone

Sign Up to like & get
recommendations!
Published in 2017 at "Gynecologic Oncology Reports"

DOI: 10.1016/j.gore.2017.05.003

Abstract: Introduction: Young women with endometrial intraepithelial hyperplasia or low-grade endometrial carcinoma are potential candidates for conservative fertility sparing therapy utilizing progesterone rather than hysterectomy. High-dose progesterone treatment is associated with 55–80% initial response but high… read more here.

Keywords: premenopausal women; aromatase inhibitor; treatment; intrauterine progesterone ... See more keywords
Photo from wikipedia

A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF.

Sign Up to like & get
recommendations!
Published in 2019 at "Reproductive biomedicine online"

DOI: 10.1016/j.rbmo.2018.12.028

Abstract: RESEARCH QUESTION Does the addition of an aromatase inhibitor improve IVF outcomes in women with endometriomas when pretreating them with gonadotrophin-releasing hormone agonists? DESIGN Retrospective two-centre cohort study involving 126 women aged 21-39 years who… read more here.

Keywords: aromatase inhibitor; treatment; rate; aromatase ... See more keywords
Photo from wikipedia

Administration of aromatase inhibitor MPV-2213ad to blue fox vixens (Vulpes lagopus) as a model for contraception in female dogs.

Sign Up to like & get
recommendations!
Published in 2020 at "Theriogenology"

DOI: 10.1016/j.theriogenology.2020.04.009

Abstract: The interest in non-surgical approaches to contraception and fertility control in female dogs has increased in recent years. In this study the effect of an aromatase inhibitor (finrozole) was evaluated in fur production animals, farmed… read more here.

Keywords: aromatase inhibitor; fox vixens; female dogs; contraception ... See more keywords
Photo by 20164rhodi from unsplash

Effect of Jianpi Bushen formula on aromatase-inhibitor-associated bone loss after menopause

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Traditional Chinese Medicine"

DOI: 10.1016/s0254-6272(18)30987-7

Abstract: Abstract OBJECTIVE To investigate the effect of Jianpi Bushen (JPBS) formula on aromatase inhibitor (AI)-associated bone loss after menopause. METHODS Six-month-old female rats were randomly divided into 6 groups: a sham group, an ovariectomized (OVX)… read more here.

Keywords: jpbs formula; aromatase inhibitor; bone loss; formula ... See more keywords